Novel variant (blaVIM-4) of the metallo-β-lactamase gene blaVIM-1 in a clinical strain of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 4026-4028

  Pournaras, Spyros ^a   Tsakris, Athanassios ^b   Maniati, Maria ^a   Tzouvelekis, Leonidas S ^c   Maniatis, Antonios N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN VIM 1; PROTEIN VIM 4; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLA VIM 1 GENE; BLA VIM 4 GENE; CASE REPORT; CEREBROSPINAL FLUID; GENE CASSETTE; GRAM NEGATIVE INFECTION; HUMAN; INTEGRON; MALE; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE HOMOLOGY; DRUG EFFECT; GENETICS; GREECE; ISOLATION AND PURIFICATION; MOLECULAR GENETICS;

BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GREECE; HUMANS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA;

EID: 0036895494     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.4026-4028.2002     Document Type: Article

References (19)

1. Cornaglia, G., A. Mazzariol, L. Lauretti, G. M. Rossolini, and R. Fontana. 2000. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin. Infect. Dis. 31:1119-1125.
2. Franceschini, N., B. Caravelli, J. D. Docquier, M. Galleni, J.-M. Frere, G. Amicosante, and G. M. Rossolini. 2000. Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase. Antimicrob. Agents Chemother. 44:3003-3007.
3. Galleni, M., J. Lamotte-Brasseur, G. M. Rossolini, J. Spencer, O. Dideberg, J.-M. Frere, and The Metallo-β-Lactamase Working Group. 2001. Standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 45:660-663.
4. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
5. VIM-2 cassette-containing novel integrons in metallo-βlactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058.
6. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
7. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: A problem in waiting? Curr. Opin. Microbiol. 3:489-495.
8. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000, Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1043.
9. National Committee for Clinical Laboratory Standards. 1999. Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. National Committee for Clinical Laboratory Standards. 2001. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
12. Pallecchi, L., M. L. Riccio, J. D. Docquier, R. Fontana, and G. M. Rossolini. 2001. Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase. FEMS Microbiol. Lett. 195:145-150.
13. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
14. VIM-2 carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45:546-552.
15. Prats, G., E. Miro, B. Mirelis, L. Poirel, S. Bellais, and P. Nordmann. 2002. First isolation of a carbapenem-hydrolyzing β-lactamase in Pseudomonas aeruginosa in Spain. Antimicrob. Agents Chemother. 46:932-933.
16. VIM-1-containing integron carrying a new aminoglyco-side phosphotransferase gene cassette. Antimicrob. Agents Chemother, 45: 1249-1253.
17. VIM metallo-β-lactamase determinants, Italy. Emerg. Infect. Dis. 3:312-313.
18. Tsakris, A., S. Pournaras, N. Woodford, M.-F. I. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000, Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
19. Yan, J.-J., P.-R. Hsueh, W.-C. Ko, K.-T. Luh, S.-H. Tsai, H.-M. Wu, and J.-J. Wu. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.